Shire Announces FDA Approval of Manufacturing Facility for VPRIV® (Velaglucerase Alfa for Injection) Drug Substance

Shire Announces FDA Approval of Manufacturing Facility for VPRIV® (Velaglucerase Alfa for Injection) Drug Substance

[CNW Group] – Shire Announces FDA Approval of Manufacturing Facility for VPRIV® (Velaglucerase Alfa for Injection) Drug Substance more

View todays social media effects on SHPG

View the latest stocks trending across Twitter. Click to view dashboard

See who Shire is hiring next, click here to view

Share this post